Can a One-Two punch of radiation and immune therapy better fight lung cancer?
NCT ID NCT03110978
Summary
This study is testing if combining a targeted, high-dose radiation treatment with an immunotherapy drug works better than radiation alone for certain early-stage or recurrent non-small cell lung cancers. About 140 participants will be randomly assigned to receive either the radiation treatment by itself or the radiation plus the immunotherapy drug nivolumab. The main goal is to see if the combination helps keep the cancer from coming back for a longer period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
MD Anderson West Houston
Houston, Texas, 77079, United States
-
MD Anderson in The Woodlands
Conroe, Texas, 77384, United States
Conditions
Explore the condition pages connected to this study.